What is 4D Molecular Therapeutics's AOCI?

4D Molecular Therapeutics (FDMT) reported AOCI of -$180K in Q1 2026.

How has 4D Molecular Therapeutics's AOCI changed year-over-year?

4D Molecular Therapeutics's AOCI decreased by 154.2% year-over-year, from $332K to -$180K.

Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.

4D Molecular Therapeutics FDMT AOCI

AOCI at other companies

Eli LillyLLY

-$2.83B+24.9%

Regeneron PharmaceuticalsREGN

$11.9M-59.1%

Vertex PharmaceuticalsVRTX

$24.8M-63.6%

EyePoint, Inc. EYPT

$802K-13.1%

AbbVieABBV

-$1.15B+33.8%

RegenxbioRGNX

-$870K-14.2%

Other financials

Income statement

See full

Revenue$3.0M+21,664%

Operating income-$73.6M-37.3%

Net income-$68.8M-43.3%

EPS (diluted)-$1.01-17.4%

Balance sheet

See full

Cash & equivalents$72.5M-45.7%

Total debt$20.5M-13.9%

Total equity$451.8M-3.8%

Total assets$512.9M-0.5%

Cash flow

See full

Operating cash flow-$68.1M-42.6%

CapEx--100%

Free cash flow-$68.1M-40.8%

Valuation

See full

Market cap$602.22M+215%

Enterprise value$550.27M+574%

P/S6.8×-8,306×

Profitability

See full

Operating margin-220.1%-110pp

Net margin-174,314.2%-62,763pp

FCF margin-154,209.2%-53,057pp

Returns & leverage

See full

Return on equity-45.4%+29.8pp

Debt / equity0×0.0×

Current ratio9.3×-3.0×

Where this comes from

Reported directly by 4D Molecular Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax.

The official record: 4D Molecular Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about 4D Molecular Therapeutics's aoci.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is 4D Molecular Therapeutics's AOCI?: 4D Molecular Therapeutics (FDMT) reported AOCI of -$180K in Q1 2026.
How has 4D Molecular Therapeutics's AOCI changed year-over-year?: 4D Molecular Therapeutics's AOCI decreased by 154.2% year-over-year, from $332K to -$180K.
What does AOCI mean?: Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.